2nd golden age in insulin market with ‘Toujeo & Tresiba’

Published: 2016-09-07 11:27:16

Updated: 2016-09-07 11:27:16

Difficulties as an injection and side effects such as hypoglycemia and weight increase…

The basal insulin market which used be considered as headache only 1-2 years ago is having the second golden age with Toujeo and Tresiba.

According to the confirmation result of the IMS Health’s data on the 6^th, Lantus(insulin glargine) recorded KRW 26.4 billion sales in the 2016 first half even with the e...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.